{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:53:36Z","timestamp":1791647616560,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.molmet.2026.102451","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:08:23Z","timestamp":1790780903000},"page":"102451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic targeting of ASAH1 in combination with carnosine as a therapeutic strategy for TNBC"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6899-9009","authenticated-orcid":false,"given":"Patrick","family":"T. Ball","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-5962","authenticated-orcid":false,"given":"Romi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.molmet.2026.102451_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival","volume":"7","author":"Onitilo","year":"2009","journal-title":"Clin Med Res"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.molmet.2026.102451_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000508759","article-title":"Optimal systemic treatment for early triple-negative breast cancer","volume":"15","author":"Furlanetto","year":"2020","journal-title":"Breast Care"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"10.1016\/j.molmet.2026.102451_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1517\/14656566.2015.1032246","article-title":"Therapies for triple negative breast cancer","volume":"16","author":"Andreopoulou","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"10.1016\/j.molmet.2026.102451_bib6","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050635","article-title":"Nutrient metabolism and cancer in the in vivo context: a metabolic game of give and take","volume":"21","author":"Altea-Manzano","year":"2020","journal-title":"EMBO Rep"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","article-title":"Cancer cells don't live alone: metabolic communication within tumor microenvironments","volume":"54","author":"Li","year":"2020","journal-title":"Dev Cell"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.molmet.2026.102451_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fonc.2018.00500","article-title":"The influence of metabolism on drug response in cancer","volume":"8","author":"Zaal","year":"2018","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.molmet.2026.102451_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13070865","article-title":"Metabolomics analysis reveals altered metabolic pathways and response to doxorubicin in drug-resistant triple-negative breast cancer cells","volume":"13","author":"Rushing","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.molmet.2026.102451_bib11","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1007\/s11033-021-06414-w","article-title":"Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis","volume":"48","author":"Arundhathi","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"11","key":"10.1016\/j.molmet.2026.102451_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrd4145","article-title":"Metabolic targets for cancer therapy","volume":"12","author":"Galluzzi","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10.1016\/j.molmet.2026.102451_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148550","article-title":"Clinical development of metabolic inhibitors for oncology","volume":"132","author":"Lemberg","year":"2022","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib16","article-title":"Targeting metabolic vulnerabilities of cancer: small molecule inhibitors in clinic","volume":"2","author":"Tripathi","year":"2019","journal-title":"Cancer Rep (Hoboken)"},{"issue":"6","key":"10.1016\/j.molmet.2026.102451_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41419-024-06831-2","article-title":"ASAH1 facilitates TNBC by DUSP5 suppression-driven activation of MAP kinase pathway and represents a therapeutic vulnerability","volume":"15","author":"Reddi","year":"2024","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.molmet.2026.102451_bib18","doi-asserted-by":"crossref","first-page":"15750","DOI":"10.18632\/aging.203170","article-title":"Acid ceramidase promotes senescent cell survival","volume":"13","author":"Munk","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.molmet.2026.102451_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101217","article-title":"N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production","volume":"48","author":"Malvi","year":"2021","journal-title":"Mol Metabol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1210\/me.2011-1150","article-title":"Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression","volume":"26","author":"Lucki","year":"2012","journal-title":"Mol Endocrinol"},{"issue":"22","key":"10.1016\/j.molmet.2026.102451_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells12222592","article-title":"The anti-cancer activity of the naturally occurring dipeptide carnosine: potential for breast cancer","volume":"12","author":"Maugeri","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.molmet.2026.102451_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41401-020-0488-1","article-title":"Carnosine suppresses human glioma cells under normoxic and hypoxic conditions partly via inhibiting glutamine metabolism","volume":"42","author":"Fang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/ol.2021.13162","article-title":"Carnosine suppresses human colorectal cancer cell proliferation by inducing necroptosis and autophagy and reducing angiogenesis","volume":"23","author":"Hsieh","year":"2022","journal-title":"Oncol Lett"},{"issue":"7","key":"10.1016\/j.molmet.2026.102451_bib24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s41401-018-0182-8","article-title":"Profiling and targeting of cellular mitochondrial bioenergetics: inhibition of human gastric cancer cell growth by carnosine","volume":"40","author":"Cheng","year":"2019","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00726-013-1627-5","article-title":"Inhibition of tumour cell growth by carnosine: some possible mechanisms","volume":"46","author":"Hipkiss","year":"2014","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.molmet.2026.102451_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26061644","article-title":"Anti-cancer effects of Carnosine-A dipeptide molecule","volume":"26","author":"Prakash","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.molmet.2026.102451_bib27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/bjc.1996.189","article-title":"Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine","volume":"73","author":"Holliday","year":"1996","journal-title":"Br J Cancer"},{"issue":"D1","key":"10.1016\/j.molmet.2026.102451_bib28","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"Hmdb 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.molmet.2026.102451_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104632","article-title":"Carnosine inhibits the proliferation of human gastric cancer SGC-7901 cells through both of the mitochondrial respiration and glycolysis pathways","volume":"9","author":"Shen","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.canlet.2011.07.021","article-title":"Carnosine inhibits KRAS-Mediated HCT116 proliferation by affecting ATP and ROS production","volume":"315","author":"Iovine","year":"2012","journal-title":"Cancer Lett"},{"issue":"11","key":"10.1016\/j.molmet.2026.102451_bib31","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1158\/1535-7163.MCT-11-0365","article-title":"Discovery and evaluation of inhibitors of human ceramidase","volume":"10","author":"Draper","year":"2011","journal-title":"Mol Cancer Therapeut"},{"issue":"3","key":"10.1016\/j.molmet.2026.102451_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2015.07.047","article-title":"Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines","volume":"464","author":"Vethakanraj","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10616-017-0154-8","article-title":"The investigation of ceranib-2 on apoptosis and drug interaction with carboplatin in human non small cell lung cancer cells in vitro","volume":"70","author":"Yildiz-Ozer","year":"2018","journal-title":"Cytotechnology"},{"issue":"6","key":"10.1016\/j.molmet.2026.102451_bib34","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s10616-016-9997-7","article-title":"Examining impacts of ceranib-2 on the proliferation, morphology and ultrastructure of human breast cancer cells","volume":"68","author":"Vejselova","year":"2016","journal-title":"Cytotechnology"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib35","first-page":"43","article-title":"Current methods for quantifying drug synergism","volume":"1","author":"Ma","year":"2019","journal-title":"Proteom Bioinform"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.15171\/apb.2019.034","article-title":"Carnosine mitigates manganese mitotoxicity in an in vitro model of isolated brain mitochondria","volume":"9","author":"Ghanbarinejad","year":"2019","journal-title":"Adv Pharmaceut Bull"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1534735416684551","article-title":"Carnosine inhibits the proliferation of human cervical gland carcinoma cells through inhibiting both mitochondrial bioenergetics and glycolysis pathways and retarding cell cycle progression","volume":"17","author":"Bao","year":"2018","journal-title":"Integr Cancer Ther"},{"issue":"9","key":"10.1016\/j.molmet.2026.102451_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jmr.2541","article-title":"Therapeutic efficacy of natural dipeptide carnosine against human cervical carcinoma cells","volume":"29","author":"Pandurangan","year":"2016","journal-title":"J Mol Recogn"},{"issue":"3","key":"10.1016\/j.molmet.2026.102451_bib39","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/adcbfa","article-title":"Improved apoptosis and mitochondrial dysfunction: the potential of carmofur-platinum nanoparticles","volume":"20","author":"Erdemir-Cilasun","year":"2025","journal-title":"Biomed Mater"},{"issue":"4","key":"10.1016\/j.molmet.2026.102451_bib40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","article-title":"Mitochondria in health, disease, and aging","volume":"103","author":"Harrington","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1016\/j.molmet.2026.102451_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101674","article-title":"Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement","volume":"37","author":"Nolfi-Donegan","year":"2020","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.32607\/actanaturae.11610","article-title":"Fifty years of research on protonophores: mitochondrial uncoupling as a basis for therapeutic action","volume":"14","author":"Kotova","year":"2022","journal-title":"Acta Nat"},{"issue":"4","key":"10.1016\/j.molmet.2026.102451_bib43","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1152\/jn.1997.78.4.1928","article-title":"Mitochondrial regulation of calcium in the Avian cochlear nucleus","volume":"78","author":"Mostafapour","year":"1997","journal-title":"J Neurophysiol"},{"issue":"6487","key":"10.1016\/j.molmet.2026.102451_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.molmet.2026.102451_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133351","article-title":"Metabolic reprogramming: a friend or foe to cancer therapy?","volume":"13","author":"McCann","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmet.2026.102451_bib46","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fonc.2020.00428","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"10","author":"Sun","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.molmet.2026.102451_bib47","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1152\/physrev.00039.2012","article-title":"Physiology and pathophysiology of carnosine","volume":"93","author":"Boldyrev","year":"2013","journal-title":"Physiol Rev"},{"issue":"Pt 4","key":"10.1016\/j.molmet.2026.102451_bib48","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1113\/jphysiol.2008.164228","article-title":"Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-Coupled PAT1 (SLC36A1) and Na+- and Cl(-)-dependent TauT (SLC6A6)","volume":"587","author":"Anderson","year":"2009","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jcp.20337","article-title":"Indirect regulation of the intestinal H+-coupled amino acid transporter hPAT1 (SLC36A1)","volume":"204","author":"Anderson","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.molmet.2026.102451_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fchem.2018.00243","article-title":"The human SLC7A5 (LAT1): the intriguing histidine\/large neutral amino acid transporter and its relevance to human health","volume":"6","author":"Scalise","year":"2018","journal-title":"Front Chem"},{"issue":"7","key":"10.1016\/j.molmet.2026.102451_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10071037","article-title":"Carnosine, small but mighty-prospect of use as functional ingredient for functional food formulation","volume":"10","author":"Jukic","year":"2021","journal-title":"Antioxidants"},{"issue":"18","key":"10.1016\/j.molmet.2026.102451_bib52","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.molcel.2022.07.012","article-title":"Stressed to death: mitochondrial stress responses connect respiration and apoptosis in cancer","volume":"82","author":"Winter","year":"2022","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.molmet.2026.102451_bib53","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.molmet.2026.102451_bib54","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/srep01035","article-title":"Discovery of highly potent acid ceramidase inhibitors with in vitro tumor chemosensitizing activity","volume":"3","author":"Realini","year":"2013","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.molmet.2026.102451_bib55","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1021\/acs.jmedchem.8b01723","article-title":"Molecular mechanism of inhibition of acid ceramidase by carmofur","volume":"62","author":"Dementiev","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.molmet.2026.102451_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.ircmb.2022.03.001","article-title":"Combination strategies to target metabolic flexibility in cancer","volume":"373","author":"Krstic","year":"2022","journal-title":"Int Rev Cell Mol Biol"},{"issue":"12","key":"10.1016\/j.molmet.2026.102451_bib57","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/s41418-025-01532-5","article-title":"Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes","volume":"32","author":"Dreute","year":"2025","journal-title":"Cell Death Differ"},{"issue":"13","key":"10.1016\/j.molmet.2026.102451_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/nu17132130","article-title":"Dietary carnosine supplementation in healthy human volunteers: a safety, tolerability, plasma and brain concentration study","volume":"17","author":"Ali","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.molmet.2026.102451_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00726-024-03414-5","article-title":"Evaluation of supplementary carnosine accumulation and distribution: an initial analysis of participants in the nucleophilic defense against PM toxicity (NEAT) clinical trial","volume":"56","author":"Baba","year":"2024","journal-title":"Amino Acids"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:43:17Z","timestamp":1791646997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877826001353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"alternative-id":["S2212877826001353"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102451","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic targeting of ASAH1 in combination with carnosine as a therapeutic strategy for TNBC","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102451"}}